Evidence map›Paper›PMID 41709213›Full record

ArticleJournal of neuroinflammation2026

St6gal1-mediated sialylation protects retinal ganglion cells by restraining microglial phagocytosis.

Liyan Liu, Jiahui Tang, Qi Zhang, Zhe Liu, Yuxuan Qiu, Bing Zhang, Yidan Liu, Yehong Zhuo, Yiqing Li

Abstract read
In one paragraph

Article in Journal of neuroinflammation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Liyan Liu *State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Sun Yat-Sen University, Guangzhou, China.
Jiahui Tang *State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Sun Yat-Sen University, Guangzhou, China.
Qi Zhang *State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Sun Yat-Sen University, Guangzhou, China.
Zhe LiuState Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Sun Yat-Sen University, Guangzhou, China.
Yuxuan QiuState Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Sun Yat-Sen University, Guangzhou, China.
Bing ZhangState Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Sun Yat-Sen University, Guangzhou, China.
Yidan LiuState Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Sun Yat-Sen University, Guangzhou, China.
Yehong ZhuoState Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Sun Yat-Sen University, Guangzhou, China. zhuoyh@mail.sysu.edu.cn.
Yiqing LiState Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Sun Yat-Sen University, Guangzhou, China. liyiqing3@mail.sysu.edu.cn.

Funding

Basic and Applied Basic Research Foundation of Guangdong Province 2023A1515110922Basic and Applied Basic Research Foundation of Guangdong Province 2024A1515013296Guangdong Basic Research Center of Excellence for Major Blinding Eye Diseases Prevention and Treatment 2024-PIZC-022National Natural Science Foundation of China 82471067National Natural Science Foundation of China 82471074Research Funds of the State Key Laboratory of Ophthalmology, the Open Research Funds of the State Key Laboratory of Ophthalmology SZ2025KF02
6 · The paper itself

Abstract

The death of retinal ganglion cells (RGCs) is a pivotal pathological event that leads to irreversible vision loss following optic nerve injury. RGCs display substantial heterogeneity, with distinct subtypes exhibiting variable resilience to injury, but the mechanisms underlying the intrinsic survival advantage remain to be defined. Here, by analyzing mouse RGC single-cell RNA sequencing datasets, we found that αRGCs expressed markedly higher levels of sialyltransferases, particularly ST6Gal1. In the mouse optic nerve crush (ONC) model, we confirmed that blockade of sialylation significantly reduced αRGC survival. Conversely, overexpression of ST6Gal1 enhanced the survival of intrinsically photosensitive RGCs and other RGCs after ONC, and conferred broad neuroprotection in additional in vivo mouse retinal injury models including I/R and NMDA excitotoxicity. Notably, overexpressing ST6TGal1 promoted optic nerve axon regeneration independent of mTOR signaling activation. Mechanistically, single-cell transcriptomic profiling revealed that ST6Gal1-mediated sialylation potentially facilitated the transition of microglia toward a homeostatic state after injury, thereby attenuating phagocytic clearance of RGCs. Together, these findings uncover a previously unrecognized sialylation-mediated regulatory axis that promotes RGC survival and optic nerve regeneration, offering a neuron-directed strategy to mitigate microglia-driven neurodegeneration.

Indexed as

MicrogliaPhagocytosisRetinal Ganglion CellsSialyltransferasesAnimalsbeta-D-Galactoside alpha 2-6-SialyltransferaseMaleMiceMice, Inbred C57BLOptic Nerve Injuriesbeta-D-Galactoside alpha 2-6-SialyltransferaseSialyltransferasesMicrogliaOptic nerve injuryRetinal ganglion cellsSialylationST6Gal1

Identifiers

PMID41709213
PMCPMC13019727

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.